Found "Vaccines": 73 results
Sort by
Last updated

Cost-utility analysis of 10- and 13- valent pneumococcal conjugate vaccines in Thailand

A model-based economic evaluation was performed to estimate costs as well as outcomes of vaccination with PCV10 and PCV13 compared to ‘no vaccination’. This study considered two commonly recommended regimens: two-dose primary series at 2 and 4 months of age plus a booster dose at age 13 months (2+1) and three-dose primary series at 2, 4 and 6 m

การวิเคราะห์ต้นทุนระบบเฝ้าระวังในโรคป้องกันด้วยวัคซีน (หัดและหัดเยอรมัน) และต้นทุนส่วนเพิ่มเพื่อการกำจัดโรคหัดและหัดเยอรมันในประเทศไทย

Department of Immunization, Vaccines and Biologicals, World Health Organization (WHO) ได้รับการสนับสนุนเงินทุนจาก Global Alliance for Vaccines and Immunization (GAVI) และ the Centers for Disease Control and Prevention (US CDC) เพื่อริเริ่มโครงการพั

Mission Report: Stakeholder Consultation Meeting on Pneumococcal Conjugate Vaccine (PCV) Project in Bhutan

Bhutan achieved Universal Child Immunization in 1991 and has maintained high immunization coverage over the past decades. Since Bhutan transitioned from Gavi support in 2016 after the country’s economic classification changed to lower‐middle income country, the government is now responsible for allo

RESEARCH REPORT: GAVI HEALTH SYSTEM STRENGTHENING SUPPORT (HSS) IN MYANMAR

In 2008, the Government of the Union of Myanmar submitted a proposal for Health Systems Strengthening Support (HSS) to Gavi, a global agency that supports children’s access to vaccines, to bolster efforts for a system-wide approach to address shortcomings in maternal and child healthcare. Approved i

WORKSHOP ON VACCINE ECONOMICS AND FOLLOW-UP ON HTA STUDIES

The International Decision Support Initiative (iDSI) lead by Health Intervention Technology Assessment Program (HITAP) has been working closely with the Health Technology Assessment Committee (HTAC) the nodal agency responsible for health technology assessment (HTA) under the Ministry of Health, Ind

Economic Evaluation of Rotavirus Vaccine in Bhutan

Bhutan is a rapidly growing economy that is transitioning from international donor support. As such, the country is looking for ways to ensure that they continue to provide the adequate services and support for their population in a rational and sustainable manner. Bhutan has begun using health tech

Christian Medical College (CMC) Vellore Research Internship to HITAP

This report aims to describe the study visit of researchers at Christian Medical College (CMC) Vellore who are undertaking cost of illness studies on enteric fever and rotavirus vaccines in India at the Health Intervention and Technology Assessment Program (HITAP). HITAP, known regionally for suppor

A Course on Vaccinology for Clinical and Public Health Practice: Policy Symposium and Workshop

This course was organised at the request of Prof. Rakesh Aggarwal, the Director of JIPMER and Prof. Gagandeep Kang, the Executive Director of THSTI and Professor at the Christian Medical College (CMC) in Vellore, India. The main objective of the course was to build technical capacity of stakeholders

Mission Report: Stakeholder Consultation Meeting on Pneumococcal Conjugate Vaccine (PCV) Project in Bhutan

Bhutan achieved Universal Child Immunization in 1991 and has maintained high immunization coverage over the past decades. Since Bhutan transitioned from Gavi support in 2016 after the country’s economic classification changed to lower‐middle income country, the government is now responsible for allo

Pritaporn Kingkaew, PhD.

Pritaporn Kingkaew has been a researcher at HITAP since 2007. She graduated from a joint programme between Srinakharinwirot University, Thailand and the University of Nottingham, UK in 2007 with a Bachelor’s degree in Pharmacy. In 2009, she was awarded the HITAP scholarship to pursue a Master’s degree in Health Economics from the University of York
10 / Page